Loading company…
ID 405134581 · FY 2019–2024 · 6 years
(ა) „კომპანიის“ ძირითადი საქმიანობა: კომპანიის ძირითადი ბიზნეს საქმიანობაა ფარმაცევტული საქონლის რეალიზაცია.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross Margin | 68.7% | 67.2% | 65.4% | 68.7% | 70.3% | 66.5% |
| EBITDA Margin | 30.6% | 25.2% | 35.8% | 39.5% | 42.7% | 35.8% |
| EBITDAR | 970 | 873 | 1,864 | 2,969 | 3,750 | 3,628 |
| EBITDAR Margin | 30.6% | 25.2% | 35.8% | 39.5% | 42.7% | 35.8% |
| EBIT Margin | 30.3% | 24.9% | 35.5% | 38.8% | 41.9% | 35.0% |
| Net Profit Margin | 29.6% | 25.2% | 35.8% | 38.6% | 41.5% | 34.7% |
| Operating Expense % of Sales | 38.1% | 42.0% | 29.6% | 29.2% | 27.6% | 30.7% |
| Returns | ||||||
| Return on Assets (ROA) | 49.7% | 36.5% | 51.1% | 57.9% | 45.8% | 35.6% |
| Return on Equity (ROE) | 76.3% | 48.4% | 66.1% | 61.3% | 53.1% | 41.6% |
| ROIC [EBIT / Invested Capital] | 61.9% | 44.2% | 61.3% | 64.3% | 55.6% | 48.5% |
| Leverage & liquidity | ||||||
| Debt-to-Assets | 17.2% | 8.9% | 10.3% | 1.6% | 6.3% | 3.7% |
| Debt-to-Equity | 0.26x | 0.12x | 0.13x | 0.02x | 0.07x | 0.04x |
| Debt-to-EBITDA | 0.33x | 0.24x | 0.20x | 0.03x | 0.13x | 0.10x |
| Equity-to-Assets | 65.1% | 75.4% | 77.4% | 94.4% | 86.2% | 85.6% |
| Net Debt | 324 | 148 | 197 | -198 | -254 | -1,137 |
| Cash & Equivalents | 0 | 65 | 177 | 281 | 756 | 1,501 |
| Total Debt | 324 | 214 | 375 | 82 | 502 | 364 |
| Efficiency & working capital | ||||||
| Inventory Turnover | 14.39x | 19.12x | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 25.4 | 19.1 | N/A | N/A | N/A | N/A |
| Receivables Turnover | 2.03x | 1.72x | 1.98x | 1.92x | 1.63x | 1.81x |
| Days Sales Outstanding (DSO) | 179.5 | 211.6 | 184.7 | 190.4 | 224.4 | 201.5 |
| Payables Turnover | 3.84x | 4.02x | 4.87x | 22.65x | 5.05x | 3.52x |
| Days Payable Outstanding (DPO) | 95.1 | 90.8 | 75.0 | 16.1 | 72.3 | 103.7 |
| Cash Conversion Cycle | 109.8 days | 139.9 days | 109.7 days | 174.3 days | 152.1 days | 97.8 days |
| Asset Turnover | 1.68x | 1.45x | 1.43x | 1.50x | 1.10x | 1.03x |
| Cash flow & dividends | ||||||
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.